Daily Archive: November 27, 2020

When second stimulus checks could arrive if Biden strikes a deal

For months Democratic and Republican leaders have failed to reach an agreement for another COVID-19 relief package, which would include items like a second round of $1,200 stimulus checks.

But staffers on Capitol Hill expect that breakthrough to come shortly after the inauguration of President-elect Joe Biden on January 20.

And if that economic aid package includes another round of stimulus checks, here’s when Americans could expect to actually get the money.

If the last go-around is any indication, the first of the checks would start to be deposited within two weeks of the legislation passing. After the passage of the $2.2 trillion CARES Act on March 27, Americans started to receive their stimulus checks as early as the week of April 13.

The long waits shouldn’t happen this time. Back in the spring, millions of Americans, including those on Social Security, saw their checks delayed until they provided additional information. … Read More

Britain and other nations press on with AstraZeneca vaccine amid trial questions By Reuters

2/2
© Reuters. FILE PHOTO: Britain’s Health Secretary Matt Hancock attends a media briefing at Downing Street, amid the coronavirus disease (COVID-19) outbreak, in London

2/2

By Alistair Smout and Karen Lema

LONDON/MANILA (Reuters) – Britain asked its regulator on Friday to assess AstraZeneca (NASDAQ:)’s COVID-19 vaccine for a possible rollout, while the Philippines and Thailand secured millions of doses, giving the shot a vote of confidence after experts raised questions about trial data.

The UK government, which has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University, has targeted a rollout to begin before Christmas.

“We have formally asked the regulator to assess the Oxford/AstraZeneca vaccine, to understand the data and determine whether it meets rigorous safety standards,” British Health Secretary Matt Hancock said.

“This letter is an important step towards deploying a vaccine as quickly as safely possible.”

In the global race to develop

Read More